Clinical Trial Update: A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) [Phase 3]

View source ↗

Summary

Phase 3 trial results for caspofungin acetate (MK0991) in Chinese adults with esophageal candidiasis or invasive candidiasis were completed and posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Caspofungin Acetate (caspofungin acetate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 3 | Status: COMPLETED | Results posted: 2012-05-28